Latest filing published 11 Sept 2026 for ARS Pharmaceuticals, Inc., €152k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Richard Lowenthal: trading record in brief
This profile gathers the share dealings of Richard Lowenthal in ARS Pharmaceuticals, Inc. The record holds 6 filings, for trades running from 18 August 2026 to 11 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 11 September 2026 with a transaction (€152k) in ARS Pharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Richard Lowenthal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,000 shares@ US$5.057CommonSEC144:0001950047-26-009340
- 75,000 shares@ US$5.61410.072% mcap31.8% of flowCommonSEC144:0001950047-26-009120
- 19,805 shares@ US$5.83510.020% mcap8.7% of flowCommonSEC144:0001950047-26-009066
- 25,000 shares@ US$5.92640.024% mcap18.7% of flowCommonSEC144:0001950047-26-008459
- 50,000 shares@ US$6.44690.052% mcap50.5% of flowCommonSEC144:0001950047-26-008376
- 50,000 shares@ US$6.31770.050% mcap100.0% of flowCommonSEC144:0001950047-26-008357
6 of 6 declarations
